Dimensional Fund Advisors LP raised its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 6.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 186,700 shares of the medical instruments supplier's stock after acquiring an additional 11,196 shares during the period. Dimensional Fund Advisors LP owned 5.51% of Utah Medical Products worth $11,476,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of UTMD. Minerva Advisors LLC raised its holdings in Utah Medical Products by 85.2% in the 4th quarter. Minerva Advisors LLC now owns 78,389 shares of the medical instruments supplier's stock valued at $4,819,000 after acquiring an additional 36,061 shares during the last quarter. Huber Capital Management LLC acquired a new stake in shares of Utah Medical Products during the 4th quarter worth $1,762,000. Royce & Associates LP increased its holdings in shares of Utah Medical Products by 159.0% during the 4th quarter. Royce & Associates LP now owns 41,958 shares of the medical instruments supplier's stock worth $2,579,000 after buying an additional 25,755 shares during the last quarter. Brandes Investment Partners LP increased its holdings in shares of Utah Medical Products by 17.8% during the 4th quarter. Brandes Investment Partners LP now owns 162,969 shares of the medical instruments supplier's stock worth $10,018,000 after buying an additional 24,604 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Utah Medical Products by 838.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 11,698 shares of the medical instruments supplier's stock worth $719,000 after buying an additional 10,452 shares during the last quarter. 69.60% of the stock is currently owned by institutional investors and hedge funds.
Utah Medical Products Price Performance
NASDAQ UTMD traded up $0.42 during trading hours on Monday, hitting $54.02. The company had a trading volume of 13,582 shares, compared to its average volume of 20,042. Utah Medical Products, Inc. has a fifty-two week low of $51.26 and a fifty-two week high of $77.33. The company has a market capitalization of $177.29 million, a price-to-earnings ratio of 13.68 and a beta of 0.30. The firm's 50 day moving average is $54.93 and its 200 day moving average is $59.99.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%. The firm had revenue of $9.71 million during the quarter.
Utah Medical Products Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, July 3rd. Investors of record on Monday, June 16th will be issued a $0.305 dividend. The ex-dividend date is Monday, June 16th. This represents a $1.22 annualized dividend and a yield of 2.26%. Utah Medical Products's dividend payout ratio is currently 32.28%.
About Utah Medical Products
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Further Reading

Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.